Analyst Insights: Apple, Syngenta, IDEX April 25th

Apple Inc. (NASDAQ:AAPL): Deutsche Bank views Apple’s guidance as conservative but expects iPhone growth to slow ahead of the October launch of the iPhone 5. Shares are Buy rated. After Apple reported stronger than expected results for its March quarter, Piper is more confident that the company’s iPhone can generate strong sales in emerging markets. The firm thinks that the company’s international growth is just beginning and it maintains an Overweight rating on the stock. Citigroup modestly raised Apple estimates based on more favorable component pricing and recommends being aggressive buyers on weakness. Shares are Buy rated.

Syngenta AG (NYSE:SYT): Syngenta and Novozymes announced a global agreement under which Syngenta will work with Novozymes to commercialize the Novozymes technology JumpStart, a seed-applied biological which increases phosphate solubility in the soil. The two companies will jointly develop the market for JumpStart in combination with Syngenta’s Seed Care portfolio on crops including cereals and corn. The agreement extends the geographic potential of JumpStart, currently sold mainly in North America, to the rest of the world.

IDEX Corporation (NYSE:IEX): Brean Murray added IDEX to its Near-Term Focus List following the better than expected Q1 report and guidance. Shares are Buy rated with a $56 price target.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.